Herbal Composition for Metabolic Syndrome Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Hyperuricemia, diabetes, and dyslipidemia often coexist in metabolic syndrome, necessitating a therapeutic agent that can effectively manage blood uric acid levels, protect pancreatic beta cells, and reduce body fat while minimizing side effects of Western medicines.
Innovation Solution
A pharmaceutical composition comprising 1-2 parts by weight of Schisandra chinensis extract and 5-10 parts by weight of Psidium guajava extract, optionally combined with extracts of Hordeum vulgare, Morus alba, Camellia sinensis, grape seed, Chromium yeast, and Momordicae sharantia, administered to reduce blood uric acid, protect pancreatic beta cells, and decrease body fat.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If Western medicines are used to treat metabolic syndrome, then blood uric acid levels are reduced, but side effects increase
Solution Approach 1:
The patent uses a composite herbal formulation combining Schisandra chinensis extract (1-2 parts by weight) and Psidium guajava extract (5-10 parts by weight) to create a synergistic therapeutic agent that reduces blood uric acid levels while minimizing side effects. This composite approach allows the combination of multiple natural compounds working together to achieve the desired therapeutic effect with improved safety profile compared to single Western pharmaceutical agents.
2Adaptability or versatility
If a single therapeutic agent is developed to treat multiple symptoms of metabolic syndrome, then treatment effectiveness is improved, but device complexity increases
Solution Approach 1:
The patent creates a universal herbal composition that simultaneously addresses multiple symptoms of metabolic syndrome including hyperuricemia, diabetes, and dyslipidemia. The formulation uses Schisandra chinensis and Psidium guajava extracts that possess multiple pharmacological activities, enabling a single agent to perform multiple therapeutic functions rather than requiring separate medications for each condition.
Solution Approach 2:
The patent merges multiple therapeutic functions into a single integrated herbal formulation. By combining extracts from Schisandra chinensis and Psidium guajava in specific weight ratios, the invention consolidates uric acid reduction, blood sugar control, and lipid management capabilities into one preparable and administrable composition, simplifying the treatment regimen despite the multifunctional requirements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces blood uric acid levels, protects pancreatic beta cells, maintains normal renal function, and decreases body fat, thereby addressing multiple symptoms of metabolic syndrome with potential benefits over traditional Western medications.
Implementation Method 1
The composition effectively reduces blood uric acid levels... by inhibiting the activity of xanthine oxidase
Implementation Method 2
protecting pancreatic beta cell... The composition effectively reduces blood uric acid levels, protects pancreatic beta cells
Implementation Method 3
decreases body fat... reducing body fat, thereby addressing multiple symptoms of metabolic syndrome
Data Source
AI summary
Provided herein is a pharmaceutical composition comprising 1-2 part by weight of Schisandra chinensis powder and 5-10 part by weight of extract of Psidium guajava L. The composition can be used in the treatment of reducing blood uric acid, protecting pancreatic beta cell, and reducing body fat.